https://doi.org/10.7490/f1000research.1114364.1
Slides
NOT PEER REVIEWED
Download
metrics
VIEWS
231
 
downloads
17
CITE
How to cite these slides:
Zamudio A. Pegylated liposomal doxorubicin for the treatment of Kaposi’s sarcoma in Maputo, Mozambique: first results of a prospective study [version 1; not peer reviewed]. F1000Research 2017, 6:1067 (slides) (https://doi.org/10.7490/f1000research.1114364.1)
NOTE: it is important to ensure the information in square brackets after the title is included in this citation.

Pegylated liposomal doxorubicin for the treatment of Kaposi’s sarcoma in Maputo, Mozambique: first results of a prospective study

Author Affiliations
  • Metrics
  • 231 Views
  • 17 Downloads
 
Part of the gateway
Browse by related subjects
Published 05 Jul 2017

Pegylated liposomal doxorubicin for the treatment of Kaposi’s sarcoma in Maputo, Mozambique: first results of a prospective study

[version 1; not peer reviewed]

Author Affiliations
1 Médecins Sans Frontières (MSF), Maputo, Mozambique
Presented at
Médecins Sans Frontières (MSF) Scientific Day Southern Africa 2017
Abstract
Competing Interests

No competing interests were disclosed

Keywords
Kaposi sarcoma, antiretroviral therapy, chemotherapy, treatment, MSF programme
Comments
0 Comments
 
Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.

Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.